Site intended for UK
audience
Site intended for UK
audience
GL Pharma was formed out of a merger of the two pharmaceutical companies Gerot and Lannacher and has a history of more than 75 years.
Welcome to GL Pharma – Shaping the Future of Healthcare Through Innovation and Excellence. Our visionary outlook drives us to redefine pharmaceutical solutions and make a lasting impact on global healthcare. With an unwavering commitment to pioneering research, advanced technology, and uncompromising quality, we aspire to enhance lives by developing cutting-edge medications and therapies. At GL Pharma, we envision a world where every individual has access to safe, effective, and affordable treatments. Join us in our journey as we strive to transform the landscape of healthcare, one breakthrough at a time.
CEO
CEO
Foundation of Lannacher Heilmittel in Lannach/Graz and Gerot Pharmazeutika in Vienna
Bartenstein family takes over Lannacher Heilmittel
Acquisition of Gerot Pharmazeutika by Lannacher Heilmittel
Start of operations at the state-of-the-art solid forms production site Lannach/Graz
Lannacher and Gerot merge under the brand Gerot Lannach
Strategic cooperation with Bausch Health in Russia and CIS markets
Doubling of production capacity as a result of Lannach/Graz production site expansion
Rebranding of GL Pharma
Company
Our products can be found in more than 50 markets worldwide. GL Pharma has more than 15 distribution structures in Europe and a subsidiary in Central America.
~1.200 employees
320 M€ GL Pharma, 450 M€ group revenue incl. Genericon Pharma
~ 5 bn defined single doses per year
In healthcare, trust is fundamental.
As a responsible company, GL Pharma is committed to transparency. Within the framework of the EFPIA Transparency Code, we disclose financial contributions to medical professionals.
